MedTrace Logo

QOL Assessment in Cancer Survivors Integrated Into Routine Clinical Care

NCT03835052 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-04-02

No results posted yet for this study

Summary

This observational cohort study of patients who received cancer treatment (of any modality) in the last 18 months are evaluated by the use of a validated QOL tool (FACT-GP) and are evaluated via telephone or in person or both. Patients with high-risk for unmet needs or distress as determined by the FACT-GP are referred to an in-person Multidisciplinary Cancer Survivorship Clinic. This is considered standard of care at the investigator's institution and is part of the continuous clinical quality improvement program within the Geisinger Cancer Institute.

Conditions

Sponsors & Collaborators

  • Geisinger Clinic

    lead OTHER

Principal Investigators

  • Christian S Adonizio, MD · Geisinger Clinic

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2020-03-25
Completion
2020-03-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03835052 on ClinicalTrials.gov